4600 Federal Register / Vol. 71, No. 18 / Friday, January 27, 2006 / Notices 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: January 19, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–778 Filed 1–26–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Musculoskeletal, Oral 

and Skin Sciences Integrated Review Group, 

Skeletal Biology Structure and Regeneration 

Study Section. 

Date: February 6–7, 2006. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Mehrdad M. Tondravi, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4108, 

MSC 7814, Bethesda, MD 20892, 301–435–

1173, tondravm@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Pathogenic 

Eukaryotes-Quorum. 

Date: February 9–10, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., Washington, DC 

20007. 

Contact Person: Robert Freund, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3200, 

MSC 7848, Bethesda, MD 20892, 301–435–

1050, freundr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Bioengineering Research Partnerships—

Imaging. 

Date: February 10, 2006. 

Time: 8:30 a.m. to 11:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 West 

Mission Drive, San Diego, CA 92109. 

Contact Person: Eileen W. Bradley, DSC, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5100, 

MSC 7854, Bethesda, MD 20892, 301–435–

1179, bradleye@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Ultrasound 

Exploratory Studies. 

Date: February 11, 2006. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 West 

Mission Drive, San Diego, CA 92109. 

Contact Person: Lee Rosen, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 5116, MSC 7854, 

Bethesda, MD 20892, 301–435–1171, 

rosenl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Ultrasound. 

Date: February 11, 2006. 

Time: 5 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 West 

Mission Bay Drive, San Diego, CA 92109. 

Contact Person: Lee Rosen, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 5116, MSC 7854, 

Bethesda, MD 20892, (301) 435–1171, 

rosenl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Fellowship—Minority and Disability 

Programs. 

Date: February 12–13, 2006. 

Time: 6 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Lindon Suite, Washington, 

DC 20037. 

Contact Person: Abdelouahab Aitouche, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2183, 

MSC 7818, Bethesda, MD 20892, 301–435–

2365, abdelouahaba@csr.nih.gov. 

Name of Committee: Oncological Sciences 

Integrated Review Group, Cancer Etiology 

Study Section. 

Date: February 13–15, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel, 1515 Rhode Island 

Ave., Washington, DC 20005. 

Contact Person: Victor A. Fung, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6178, 

MSC 7804, Bethesda, MD 20892, 301–435–

3504, fungv@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, 

Pregnancy and Neonatology Study Section. 

Date: February 13–14, 2006. 

Time: 8 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Michael Knecht, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6176, 

MSC 7892, Bethesda, MD 20892, (301) 435–

1046, knechtm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Bioengineering Research Applications—

Respiratory. 

Date: February 13, 2006. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Everett E. Sinnett, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2178, 

MSC 7818, Bethesda, MD 20892, 301–435–

1016, sinnett@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, High End 

Mass Spectrometers. 

Date: February 14, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW., Washington, DC 20009. 

Contact Person: David R. Jollie, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5158, 

MSC 7806, Bethesda, MD 20892, (301) 435–

1722, jollieda@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group, Macromolecular Structure 

and Function B Study Section. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW., Washington, DC 20009. 

Contact Person: Nancy Lamontagne, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4170, 

MSC 7806, Bethesda, MD 20892, (301) 435–

1726, lamontan@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 


rmajette on PROD1PC67 with NOTICES
Federal Register / Vol. 71, No. 18 / Friday, January 27, 2006 / Notices 4601 

Group, Language and Communication Study 

Section. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Weijia Ni, PhD., Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 3190, MSC 7848, (for 

overnight mail use room # and 20817 zip), 

Bethesda, MD 20892, (301) 435–1507, 

niw@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Clinical and 

Integrative Diabetes and Obesity. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Nancy Sheard, SCD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6046–E, 

MSC 7892, Bethesda, MD 20892, (301) 435–

1154, sheardn@csr.nih.gov. 

Name of Committee: Immunology 

Integrated Review Group, Immunity and Host 

Defense. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Washington, Pennsylvania 

Ave at 15th Street, NW., Washington, DC 

20004. 

Contact Person: Patrick K. Lai, PhD., 

Scientific Review Administrator, National 

Institutes of Health, Center for Scientific 

Review, 6701 Rockledge Drive, Room 2215, 

MSC 7812, Bethesda, MD 20892, 301–435–

1052, laip@csr.nih.gov. 

Name of Committee: Health of the 

Population Integrated Review Group, 

Cardiovascular and Sleep Epidemiology 

Study Section. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select Bethesda, 8120 

Wisconsin Ave, Bethesda, MD 20814. 

Contact Person: J. Scott Osborne, PhD., 

MPH, Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 4114, MSC 7816, Bethesda, MD 20892, 

(301) 435–1782, osbornes@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships. 

Date: February 16, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select Bethesda, 8120 

Wisconsin Ave, Bethesda, MD 20814. 

Contact Person: Khalid Masood, PhD., 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5095H, 

MSC 7854, Bethesda, MD 20892, 301–402–

3962, masoodk@csr.nih.gov. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group, Cellular Mechanisms in Aging and 

Development Study Section. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: James P. Harwood, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5168, 

MSC 7840, Bethesda, MD 20892, 301–435–

1256, harwoodj@csr.nih.gov. 

Name of Committee: Hematology 

Integrated Review Group, Hematopoiesis 

Study Section. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Robert T. Su, PhD, 

Scientific Review Administrator, Cener for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4134, 

MSC 7802, Bethesda, MD 20892, (301) 435–

1195, sur@csr.nih.gov. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group, Development—1 Study Section. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The River Inn, 924 25th Street, NW., 

Washington, DC 20037. 

Contact Person: Sherry L. Dupere, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5136, 

MSC 7843, Bethesda, MD 20892, (301) 435–

1021, duperes@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group, Molecular 

Genetics C Study Section. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Barbara Whitmarsh, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2206, 

MSC 7890, Bethesda, MD 20892, (301) 435–

4511, whitmarshb@csr.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group, Neurobiology of 

Learning and Memory Study Section. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: George Washington University Inn, 

824 New Hampshire Ave., NW., Washington, 

DC 20037. 

Contact Person: Bernard F. Driscoll, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5184, 

MSC 7844, Bethesda, MD 20892, 301–435–

1242, driscolb@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group, Nuclear Dynamics 

and Transport. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Wyndham Washington, DC, 1400 M 

Street, NW., Washington, DC 20005. 

Contact Person: Charles R. Dearolf, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5142, 

MSC 7840, Bethesda, MD 20892, 301–435–

1024, dearolfc@csr.nih.gov. 

Name of Committee: Immunology 

Integrated Review Group, Hypersensitivity, 

Autoimmune, and Immune-mediated 

Diseases. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Jurys Washington Hotel, 1500 New 

Hampshire Avenue, NW., Washington, DC 

20036. 

Contact Person: Bahiru Gametchu, DVM, 

MS, PhD, Scientific Review Administrator, 

Center for Scientific Review, National 

Institute of Health, 6701 Rockledge Drive, 

Room 4204, MSC 7812, Bethesda, MD 20892, 

301–435–1225, gametchb@csr.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group, Neurotoxicology 

and Alcohol Study Section. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: Hilton Washington Embassy Row, 

2015 Massachusetts Ave., NW., Washington, 

DC 20036. 

Contact Person: Joseph G. Rudolph, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7844, Bethesda, MD 20892, 301–435–

2212, josephru@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group, Biobehavioral Mechanisms of 

Emotion, Stress and Health Study Section. 

Date: February 16–17, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Maribeth Champoux, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3182, 

MSC 7759, Bethesda, MD 20892, 301–594–

3163, champoum@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group, Adult Psychopathology and Disorders 

of Aging Study Section. 


rmajette on PROD1PC67 with NOTICES
4602 Federal Register / Vol. 71, No. 18 / Friday, January 27, 2006 / Notices 

Date: February 16–17, 2006. 

Time: 8:30 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW., 

Washington, DC, 20036. 

Contact Person: Mariela Shirley, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7848, Bethesda, MD 20892, 301–435–

0913, shirleym@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group, Neurogenesis and Cell Fate 

Study Section. 

Date: February 16–17, 2006. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Washington, DC, 20037. 

Contact Person: Lawrence Baizer, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4152, 

MSC 7850, Bethesda, MD 20892, 301–435–

1257, baizerl@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group, Biophysics of Synapses, 

Channels, and Transportation Study Section. 

Date: February 16–17, 2006. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Little America Hotel, 500 South 

Main Street, Salt Lake City, UT 84101. 

Contact Person: Michael A. Lang, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4140, 

MSC 7850, Bethesda, MD 20892, 301–435–

1265, langm@csr.nih.gov. 

Name of Committee: Health of the 

Population Integrated Review Group, Nursing 

Science: Children and Families Study 

Section. 

Date: February 16, 2006. 

Time: 8:30 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Fungai F. Chanetsa, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3028B, 

MSC 7770, Bethesda, MD 20892, 301–435–

1262, chanetsaf@csr.nih.gov. 

Name of Committee: Hematology 

Integrated Review Group, Hemostasis and 

Thrombosis Study Section. 

Date: February 16–17, 2006. 

Time: 8:30 a.m. to 10 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hills 

Road, Bethesda, MD 20814. 

Contact Person: Chhanda L. Ganguly, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7802, Bethesda, MD 20892, 301–435–

1729, gangulyc@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group, Molecular 

Genetics B Study Section. 

Date: February 16–17, 2006. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, Washington, DC 20037. 

Contact Person: Richard A. Currie, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5128, 

MSC 7840, Bethesda, MD 20892, 301–435–

1219, currieri@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromulecular Biophysics Integrated 

Review Group, Synthetic and Biological 

Chemistry B Study Section. 

Date: February 16–17, 2006. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., Washington, DC 

20007. 

Contact Person: Mike Radtke, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4176, 

MSC 7806, Bethesda, MD 20892, 301–435–

1728, radtkem@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group, Enabling Bioanalystical and 

Biophysical Technologies Study Section. 

Date: February 16–17, 2006. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate, 2650 Virginia 

Avenue, NW., Washington, DC 20037. 

Contact Person: Noni Byrnes, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4180, 

MSC 7806, Bethesda, MD 20892, (301)–435–

1217, byrnesn@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Kidney, 

Nutrition, Obesity and Diabetes (KNOD) 

Epidemiology. 

Date: February 16–17, 2006. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Christopher T. Sempos, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3146, 

MSC 7770, Bethesda, MD 20892, (301) 451–

1329, semposch@csr.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group, Biological Rhythms 

and Sleep Study Section. 

Date: February 16, 2006. 

Time: 8:30 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Michael Selmanoff, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3134, 

MSC 7844, Bethesda, MD 20892–7844, 301–

435–1119, mselmanoff@scr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cell Biology 

R01 Review. 

Date: February 16, 2006. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Alexandra M. Ainsztein, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5144, 

MSC 7840, Bethesda, MD 20892, 301–451–

3848, ainsztea@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Genetics of 

Complex Diseases. 

Date: February 16, 2006. 

Time: 3 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Barbara J. Thomas, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2220, 

MSC 7890, Bethesda, MD 20892, 301–435–

0603, bthomas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Malaria. 

Date: February 16, 2006. 

Time: 3 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Fouad A. El-Zaatari, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3206, 

MSC 7808, Bethesda, MD 20814–9692, 301–

435–1149, elzaataf@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Biobehavioral Mechanisms in 

Psychopathology, Sleep, and Eating 

Disorders. 

Date: February 17, 2006. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW., 

Washington, DC 20036. 

Contact Person: Mariela Shirley, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7848, Bethesda, MD 20892, 301–435–

0913, shirleym@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflicts: Auditory Processes. 

Date: February 17, 2006. 

Time: 1 p.m. to 3:30 p.m. 


rmajette on PROD1PC67 with NOTICES
Federal Register / Vol. 71, No. 18 / Friday, January 27, 2006 / Notices 4603 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Christine L. Melchior, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5176, 

MSC 7844, Bethesda, MD 20892, 301–435–

1713, melchioc@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 19, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–780 Filed 1–26–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Toxicology Program (NTP), 

NTP Interagency Center for the 

Evaluation of Alternative Toxicological 

Methods (NICEATM); Nomination To 

Hold a Workshop on Alternative 

Methods To Replace the Mouse LD50

Assay for Botulinum Toxin Potency 

Testing: Request for Comments, 

Nominations of Experts, and 

Submission of In Vivo and In Vitro Data 

AGENCY: National Institute of 

Environmental Health Sciences 

(NIEHS), National Institutes of Health 

(NIH). 

ACTION: Request for comments, 

nominations of scientific experts, and 

submission of data. 

SUMMARY: In October 2005, the Humane 

Society of the United States (HSUS) 

submitted a nomination to NICEATM 

requesting that alternative test methods 

to the mouse LD50 assay for botulinum 

toxin potency testing be assessed and 

prioritized for prevalidation and 

validation efforts. The nomination 

proposed that an initial key step in this 

process would be for the Interagency 

Coordinating Committee on the 

Validation of Alternative Methods 

(ICCVAM) to organize a workshop on 

this topic. ICCVAM considered the 

nomination and supports with a high 

priority the concept of a workshop to 

discuss alternative methods and 

approaches that might reduce, refine, or 

replace the use of animals for botulinum 

potency testing. The Scientific Advisory 

Committee on Alternative Toxicological 

Methods (SACATM) considered the 

nomination and the ICCVAM proposal 

at its meeting on December 12, 2005, 

and agreed that the proposed activity 

should have a high priority. At this 

time, NICEATM requests (1) information 

on development and/or validation 

activities relevant to reduction, 

refinement (less pain and distress), and/ 

or replacement alternatives for 

botulinum toxin potency testing, (2) 

public comments on the 

appropriateness and relative priority of 

proceeding with a workshop on this 

topic, (3) the nomination of scientific 

experts who might participate if a 

workshop occurs, and (4) the 

submission of data from mouse LD50

botulinum potency testing and ex vivo 

and in vitro test methods used for 

botulinum toxin potency testing. The 

HSUS nomination is available at 

http://iccvam.niehs.nih.gov/ see 

‘‘Nominations and Submissions.’’

DATES: Comments, nominations of 

expert scientists, and data submissions 

should be received by March 13, 2006. 

ADDRESSES: Correspondence should be 

sent by mail, fax, or e-mail to Dr. 

William S. Stokes, NICEATM Director, 

NIEHS, P.O. Box 12233, MD EC–17, 

Research Triangle Park, NC 27709, 

(phone) 919–541–2384, (fax) 919–541–

0947, (e-mail) niceatm@niehs.nih.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

In October 2005, the HSUS submitted 

a nomination to NICEATM to organize 

a workshop to evaluate the state-of-thescience for potential alternatives to the 

mouse LD50 assay for botulinum toxin 

potency testing. The HSUS nomination 

is available at http:// 

iccvam.niehs.nih.gov/ see ‘‘Nominations 

and Submissions.’’ ICCVAM considered 

the nomination and supports the 

concept of a workshop to discuss 

alternative methods and approaches that 

might reduce, refine, or replace the use 

of animals for botulinum potency 

testing with a high priority. The 

SACATM discussed this nomination at 

its meeting on December 12, 2005, and 

advised NICEATM and ICCVAM that 

they consider the development and 

validation of alternatives to the mouse 

LD50 assay for botulinum toxin potency 

testing a high priority. SACATM also 

suggested that prior to convening a 

workshop that ICCVAM and NICEATM 

find out what efforts toward developing 

or validating alternatives might already 

be underway by companies that conduct 

botulinum potency testing. NICEATM 

now seeks (1) information on any 

activities directed at the development 

and/or validation of alternatives to the 

mouse LD50 assay for botulinum toxin 

potency testing, (2) input from the 

public on this nomination for a 

workshop, (3) the nomination of 

scientific experts who might participate 

in any future workshop on this topic 

should it occur, as well as (4) data from 

mouse LD50 botulinum potency testing 

and ex vivo and in vitro test methods 

used for botulinum toxin potency 

testing. NICEATM and ICCVAM will 

consider this information and determine 

how to best move forward with this 

nomination. 

Request for Comments, Nominations of 

Scientific Experts and Request for Data 

NICEATM requests information on 

the status of any efforts to develop 

alternatives to the mouse LD50 assay for 

botulinum toxin potency testing, as well 

as public comments on the 

appropriateness and relative priority of 

the proposed workshop activity. In 

addition, NICEATM requests the 

nomination of scientists with relevant 

knowledge and experience to 

potentially participate in the workshop 

should it be held. Areas of relevant 

expertise include, but are not limited to: 

neurophysiology, neuropharmacology, 

neurotoxicity, immunology, potency 

testing of toxins and other biologicals in 

animals and in vitro systems, 

development and use of in vitro 

methodologies, and biostatistical data 

analysis. Each nomination should 

include the person’s name, affiliation, 

contact information (i.e., mailing 

address, e-mail address, telephone and 

fax numbers), and a brief summary of 

relevant experience and qualifications. 

NICEATM invites the submission of 

data from in vivo botulinum toxin 

potency testing, including clinical 

observations and corresponding timecourse information, and information 

and data from ex vivo and in vitro test 

methods being used as potential 

alternatives to the mouse assay for 

botulinum toxin potency testing. 

Submitted data will be used to further 

evaluate the usefulness and limitations 

of in vitro potency test methods and 

may be included in future NICEATM 

and ICCVAM reports and publications 

as appropriate. The data will also be 

included in a NICEATM database to 

support the investigation of alternative 

test methods for assessing potency of 

botulinum toxin. 

When submitting chemical and 

protocol information/test data, please 

reference this Federal Register notice 

and provide appropriate contact 

information (name, affiliation, mailing 

address, phone, fax, e-mail, and 

sponsoring organization, as applicable). 

NICEATM prefers data to be 

submitted as copies of pages from study 


rmajette on PROD1PC67 with NOTICES